Aeglea BioTherapeutics Inc. (AGLE) Gained 5.33% or 0.32 To Price $6.32 On Friday

Aeglea BioTherapeutics Inc. (AGLE) gained 5.33% or 0.32 to $6.32. It is close to 84674 shares traded, which is 110.82% compare to the average total volume 76407. The market cap of AGLE is $105.19 million. The year to date change is 11.52%. The 52 week price range is from $2.81 to $8.14. Price of AGLE have changed 8.70% during last week. It have changed 15.38% over last month, 10.50% over last 3 months, 74.42% over last 6 months and 15.83% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 4.88. It is -22.78% below current price. The 200-day Moving Averages for AGLE is 4.83. It is -23.58% below current price. The 52-week High is 8.14. It is 28.80% from the current price. The 52-week Low is 2.81. It is -55.54% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AGLE is 0.52 on 2017-12-15. Short % to float is 0.23%. There are some statistics of AGLE. It is has market cap $105.19 million. The share outstanding is 16.64 million. The average volume is 76407. The percent of top 15 Institution holding is 63.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -42.42%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -39.58%.


Share this post